Stock Movers

On this episode of Stock Movers:
- Alphabet (GOOG) shares rose more than 2% in postmarket trading after The Information reported Meta Platforms is in talks to spend billions of dollars to use Google’s AI-focused chips, known as TPUs, in their own data centers and also rent the chips from Google Cloud, citing a person familiar.
- Nvidia (NVDA) shares fell on a report that Meta Platforms Inc. is in talks to spend billions on Google’s AI chips, suggesting the internet search leader is making headway in efforts to rival the industry’s bestselling AI accelerator.
- Alibaba Group (BABA) posted better-than-projected 34% growth in its pivotal cloud business, highlighting the enormous demand for computing during China’s AI boom.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- ABN Amro Bank NV plans to cut almost 20% of its workforce as new Chief Executive Officer Marguerite Berard seeks to boost profitability.
- Shares of UK lenders rose as worries eased that Rachel Reeves was planning to hike taxes on the UK’s biggest banks as part of Wednesday’s budget.
- Marston’s shares climb as much as 12% in London to the highest level since June 2022, after the pub operator reported results ahead of analysts’ estimates on Tuesday and said Christmas bookings are strong.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- ABN Amro Bank NV plans to cut almost 20% of its workforce as new Chief Executive Officer Marguerite Berard seeks to boost profitability.
- Kingfisher shares climb as much as 6.9% after the home-improvement retailer raised its full-year earnings guidance and reported third-quarter sales that were slightly ahead of estimates.
- European defense stocks including Rheinmetall may be active in early trading after Russia and Ukraine exchanged fire with heavy air raids on Kyiv and assaults on southern Russian areas

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:

- Zoom (ZM) reported quarterly revenue that topped analysts’ estimates, a sign of strength for the software maker’s expanded suite of business tools. Fiscal third-quarter sales increased 4.4% to $1.23 billion, Zoom said Monday in a statement. Profit, excluding some items, was $1.52 a share. Analysts, on average, estimated earnings of $1.44 a share on revenue of $1.21 billion, according to data compiled by Bloomberg. The shares gained about 4% in extended trading after closing Monday at $78.60 in New York. The stock has declined 3.7% this year amid a broader market anxiety toward application software.

- Tesla (TSLA) is nearing the final step of the design process for its AI5 chip and starting work on a new AI6 chip to be deployed in its cars and data centers, Tesla CEO Elon Musk said Sunday in an X post. “Our goal is to bring a new AI chip design to volume production every 12 months,” said Musk, the world’s richest person. “The current version in cars is AI4, we are close to taping out AI5 and are starting work on AI6.” Shares of the EV-maker rallied.

- Tyson Foods (TSN) saw its shares rally after it decided it close a major packing plant in Nebraska. The company on Friday said it was seeking to “right-size its beef business” by ending operations in Lexington, Nebraska, and converting the plant in Amarillo, Texas, to a single shift. About 3,200 workers will be impacted in Lexington and 1,700 in Amarillo, Tyson said.

See omnystudio.com/listener for privacy information.

Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Scarlet Fu, Katie Greifeld, Tim Stenovec and Carol Massar.

On this episode of Stock Movers:

- Alphabet (GOOGL) closed higher on last week's glowing reviews for the Gemini AI model. The stock has risen almost 13% this month, and it is up nearly 70% this year, by far the top performer among the Mag 7

- E.W. Scripps (SSP) rose on a proposal by Sinclair to buy all outstanding shares of E.W. Scripps it does not already own for $7.00 per share, consisting of $2.72 in cash and $4.28 in combined company common stock.

- Novo Nordisk (NVO) closed 5.5% lower. Shares dropped after a pill version of Ozempic failed to slow the progression of Alzheimer’s disease in a pair of long-shot studies that aimed to open up a new use for blockbuster obesity drugs.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:

- Novo Nordisk (NVO) dropped after a pill version of Ozempic failed to slow the progression of Alzheimer’s disease in a pair of long-shot studies that aimed to open up a new use for blockbuster obesity drugs.

- Amazon (AMZN) is rising. The company says it will spend as much as $50 billion, expanding its capacity to provide artificial intelligence and high-performance computing services to US government entities.

- Tesla (TSLA) shares jumped around 7% on Monday after a Sunday post on X from Elon Musk commenting on the company’s AI chip plans.

See omnystudio.com/listener for privacy information.

Bristol-Myers (BMY)

• Analysts are citing a positive readacross to Bristol-Myers from positive results for Bayer's experimental stroke-prevention drug
• Cantor: Bayer’s data supports confidence in BMY’s own program in secondary stroke prevention
• Earlier this month:  shares fell after one of its most important experimental medicines appeared unlikely to benefit patients who had suffered a heart complication, another setback for the drugmaker’s product pipeline

Cooper (COO)

• Maker of medical devices and surgical instruments;
• Activist investors Browning West wrote a letter to the board saying its “inadequate” oversight has led the company to significantly underperform and miss financial guidance
• Calls for urgent change at the Board to refocus the co. and appoint Browning West’s director candidates
• Urges Cooper to pause any potential restructuring efforts until Browning West’s recommended directors are seated so that any restructuring is optimized in scope and magnitude
• Reuters reported earlier this month that Browning West owns about 4% of Cooper

WBD

• Netflix, Comcast and Paramount Skydance all submitted bids for Warner Bros. Discovery by the Nov. 20 deadline for a first bid
• Comcast and Netflix are most interested in the film and TV library; Paramount is willing to buy the whole company
• Fourth owner in seven years
• Warner Bros. may not reach a deal with any of the suitors and may continue its current plan to separate its flagging cable networks from the rest of the businesses next year

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
Oracle (ORCL)

• Oracle credit-default swaps -- cost of protecting Oracle's debt against default rose to the highest in more than three years
• Oracle's AI spending spree is raising questions over how exactly the company is going to fund its deals, especially since it has a weaker credit rating than Microsoft or Alphabet -- it's quickly emerging as the credit market’s barometer for AI risk
• Stock slumped 11% last week, six-week stretch of declines -- losses also caused a $130 billion hit to Larry Ellison's net worth after the rally in September briefly made him the world's riches person

Alphabet (GOOGL)

• Leads the rally on Monday given continued optimism over the latest version of its Gemini AI model
• Last week: The Information reported that OpenAI CEO Sam Altman recently told colleagues that Alphabet’s progress in AI could “create some temporary economic headwinds for our company”
• Bloomberg Intelligence: excess returns year-to-date are the weakest among investment grade tech peers excluding Oracle; consequence of its considerable defensive credit characteristics and tight spreads vs. fundamentals

Centene (CNC)

• Climbing with other health insurers after Politico reported the White House is expected to propose a two-year extension of Obamacare subsidies with new limits on eligibility
• MS NOW also reported that President Donald Trump is expected to announce a general framework to address health care costs and spikes in ACA insurance premiums
• Centene offers health insurance plans under the Affordable Care Act (ACA) marketplace

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- A pill version of Novo Nordisk (NOVOB) Ozempic failed to slow the progression of Alzheimer’s disease in a pair of high-risk studies that aimed to open up a new use for blockbuster obesity drugs. Patients who took the medicine didn’t see their disease progress more slowly based on a cognitive assessment, the Danish drugmaker said Monday. Novo will discontinue a planned one-year extension of the studies. The stock plunged as much as 12.4% in Copenhagen, hitting the lowest level since July 2021.
- Alibaba Group's (BABA) Qwen app drew more than 10 million downloads in the week after its relaunch, boding well for a longer-term effort to build a rival to OpenAI’s ChatGPT. - Biogen (BIIB) shares rise 4.7% in premarket trading on Monday after Novo Nordisk said a pill version of Ozempic failed to slow the progression of Alzheimer’s disease in two late-stage studies. Wall Street analysts see a positive read-through to Biogen.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Alphabet (GOOG) shares soared the most in two months on Wednesday as a wave of glowing reviews for the newly released version of its Gemini artificial intelligence model spurred investor confidence about the company’s position in the ever-changing tech landscape.
- Eli Lilly (LLY) shares slump after Novo Nordisk said its Evoke late-stage trials did not demonstrate a statistically significant reduction in Alzheimer’s disease progression. - RTX and Israeli defense firm Rafael have won a $1.25 billion contract to build surface-to-air missiles for Israel’s Iron Dome air-defense system at a new plant in Arkansas, the joint venture announced. The deal marks the first production contract for the partnership at the new facility, based in Camden, in south central Arkansas. The two companies invested $33 million to build the facility, which opened earlier this month.

See omnystudio.com/listener for privacy information.